Table 3.
Clinical characteristics of patients who underwent genome biopsy with EBUS-TBNA
| EBUS-TBNA patients (n = 134) | (%) | Re-biopsy patients (n = 9) | (%) | ||
|---|---|---|---|---|---|
| Age-median, [range] | Median | 68 [30–89] | 69 [35–73] | ||
| Sex-no. (%) | Male | 101 | (75.4) | 8 | (41.6) |
| Female | 33 | (24.6) | 1 | (58.4) | |
| Histology-no. (%) | Ad | 78 | (58.2) | 5 | (58.4) |
| Sq | 28 | (20.9) | 2 | (20.8) | |
| NSCLC | 28 | (20.9) | 2 | (20.8) | |
| Stage-n. (%) | IVA, B | 83 | (61.9) | 5 | (55.6) |
| IIIA,B,C | 51 | (38.1) | 4 | (44.4) | |
| Tumor location | #2 | 3 | (2.2) | 0 | |
| #4 | 60 | (44.8) | 2 | (22.2) | |
| #7 | 40 | (29.9) | 3 | (33.4) | |
| #10 | 4 | (3.0) | 1 | (11.1) | |
| #11 | 9 | (6.7) | 0 | ||
| #12 | 5 | (3.7) | 0 | ||
| Upper lobe | 4 | (3.0) | 1 | (11.1) | |
| Lower lobe | 8 | (6.0) | 2 | (22.2) | |
| Other | 1 | (0.7) | 0 | ||
| ROSE | Positive | 8 | (88.9) | ||
EBUS-TBNA Endobronchial ultrasound-guided transbronchial needle aspiration, ROSE rapid-onsite evaluation